New Stock News | Anji Biological Plans to List on the Hong Kong Stock Exchange. The China Securities Regulatory Commission requires additional clarification on whether the continuous compliance with foreign investment entry policies before and after this issuance and listing.

According to the Wise Finance APP, on September 5th, the China Securities Regulatory Commission announced the "Supplementary Material Requirements for Overseas Issuance and Listing Approval (August 29, 2025 - September 4, 2025)", and the International Department of the CSRC issued supplementary material requirements for 12 companies. Among them, Anmai Biosciences was required to provide additional information on whether they continue to meet the requirements of foreign investment access policies before and after this issuance and listing. According to the Hong Kong Stock Exchange disclosed on June 17th, Anmai Biosciences Technology Co., Ltd. submitted a listing application to the main board of the Hong Kong Stock Exchange, with CITIC Securities and CICC acting as joint sponsors.